Front | Back |
Drug Class
|
Sympathomimetic
|
Mechanism of Action
|
Direct acting alpah and beta agonist. Alpha: vasoconstriction. Beta-1: postive inotropic, chronotropic, and dromotropic effects. Beta-2: bronchial smooth muscle relation and dilation of skeletal vasculature. Blocks histamine receptors.
|
How Supplied
|
1:1,000 solution: Ampules and vials containing 1 mg/ml . 1:10,000 solution: Prefilled syringes containing 0.1 mg/ml. Auto injector (EpiPen): 0.5 mg/ml (1:2,000)
|
Indications
|
Cardiac arrest (asystole, PEA, ventricular)
|
Contraindications
|
Hypertension, Pulmonary edema
|
Adverse Reactions / Side Effects
|
Pulmonary edema, Chest pain
|
Drug Interactions
|
Potentiates other sympathomimetics. Deactivated by alkaline solutions. MAOIs may potentiate effect. Beta blockers may blunt effects.
|
Dosage and Administration
|
Mild allergic reactions and asthma: Adult; 0.3 - 0.5mg (0.3 - 0.5ml) of 1:1,000 solution IM/SC Pediatric: 0.01 mg/kg (0.01ml/kg) of a 1:1,000 solution SC (maxium 0.3mL) Anaphylaxis / Severe Status Asthmaticus: Adult; 0.1 mg (1mL) of 1:10,000 solution IV. Pediatric; 0.01mg/kg (0.01mL/kg) IM of a 1:1,000 solution (maximum single dose: 0.3mg) Symptomatic Bradycardia: IV/IO dose: 0.01 mg/kg (0.01 mL/kg) of a 1:10,000 solution
|
Duration
|
Onset:Immediate Peak Effect: Minutes Duration: Several minutes
|
Special Considerations
|
Pregnancy safety: Category C. May cause syncope in asthmatic children. May increase myocardial oxygen demand
|